These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22257795)

  • 1. Endothelin in hypertension: an update.
    Rautureau Y; Schiffrin EL
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):128-36. PubMed ID: 22257795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular gene expression in mice overexpressing human endothelin-1 targeted to the endothelium.
    Simeone SM; Li MW; Paradis P; Schiffrin EL
    Physiol Genomics; 2011 Feb; 43(3):148-60. PubMed ID: 21045115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
    Kern JM; Maass V; Rupp J; Maass M
    Thromb Haemost; 2009 Oct; 102(4):743-53. PubMed ID: 19806261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation.
    Anggrahini DW; Emoto N; Nakayama K; Widyantoro B; Adiarto S; Iwasa N; Nonaka H; Rikitake Y; Kisanuki YY; Yanagisawa M; Hirata K
    Cardiovasc Res; 2009 Apr; 82(1):143-51. PubMed ID: 19164391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
    Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R; Lebel M
    Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 exacerbates development of hypertension and atherosclerosis in modest insulin resistant syndrome.
    Lin YJ; Juan CC; Kwok CF; Hsu YP; Shih KC; Chen CC; Ho LT
    Biochem Biophys Res Commun; 2015 May; 460(3):497-503. PubMed ID: 25824048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 decreases CD36 protein expression in vascular smooth muscle cells.
    Kwok CF; Juan CC; Ho LT
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E648-52. PubMed ID: 16985264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets.
    Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of endothelin-1 and its receptor blockers on the liver function.
    Michalski Ł; Kleniewska P; Piechota-Polańczyk A; Gorąca A
    Gen Physiol Biophys; 2012 Dec; 31(4):383-8. PubMed ID: 23255664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist-evoked calcium entry in vascular smooth muscle cells requires IP3 receptor-mediated activation of TRPC1.
    Tai K; Hamaide MC; Debaix H; Gailly P; Wibo M; Morel N
    Eur J Pharmacol; 2008 Mar; 583(1):135-47. PubMed ID: 18289524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Month Endothelial Human Endothelin-1 Overexpression Causes Blood Pressure Elevation and Vascular and Kidney Injury.
    Coelho SC; Berillo O; Caillon A; Ouerd S; Fraulob-Aquino JC; Barhoumi T; Offermanns S; Paradis P; Schiffrin EL
    Hypertension; 2018 Jan; 71(1):208-216. PubMed ID: 29133362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent blood pressure elevation is due to increased vascular smooth muscle tone mediated by G-protein signalling.
    Wirth A; Wang S; Takefuji M; Tang C; Althoff TF; Schweda F; Wettschureck N; Offermanns S
    Cardiovasc Res; 2016 Jan; 109(1):131-40. PubMed ID: 26531127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension during vascular endothelial growth factor inhibition: focus on nitric oxide, endothelin-1, and oxidative stress.
    Lankhorst S; Kappers MH; van Esch JH; Danser AH; van den Meiracker AH
    Antioxid Redox Signal; 2014 Jan; 20(1):135-45. PubMed ID: 23458507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vascular endothelin system in hypertension--recent patents and discoveries.
    Hynynen MM; Khalil RA
    Recent Pat Cardiovasc Drug Discov; 2006 Jan; 1(1):95-108. PubMed ID: 17200683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulators of the vascular endothelin receptor in blood pressure regulation and hypertension.
    Khalil RA
    Curr Mol Pharmacol; 2011 Nov; 4(3):176-86. PubMed ID: 21222646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelin and essential hypertension].
    Kataoka K; Kurihara Y; Kurihara H
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():640-3. PubMed ID: 15506465
    [No Abstract]   [Full Text] [Related]  

  • 20. Deleterious effect in endothelin receptor-mediated coronary artery smooth muscle contractility in high-salt diet rats.
    Xiao H; Lu H; Xue Y; Jia Z; Dai M; He K; Zhao R
    Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):234-244. PubMed ID: 36404239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.